EA200200939A1 - Способ получения циталопрама - Google Patents

Способ получения циталопрама

Info

Publication number
EA200200939A1
EA200200939A1 EA200200939A EA200200939A EA200200939A1 EA 200200939 A1 EA200200939 A1 EA 200200939A1 EA 200200939 A EA200200939 A EA 200200939A EA 200200939 A EA200200939 A EA 200200939A EA 200200939 A1 EA200200939 A1 EA 200200939A1
Authority
EA
Eurasian Patent Office
Prior art keywords
halogen
formula
citalopram
followed
defined above
Prior art date
Application number
EA200200939A
Other languages
English (en)
Other versions
EA005491B1 (ru
Inventor
Майкл Харолд Рок
Халех Ахмадиан
Original Assignee
Х.Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х.Лундбекк А/С filed Critical Х.Лундбекк А/С
Publication of EA200200939A1 publication Critical patent/EA200200939A1/ru
Publication of EA005491B1 publication Critical patent/EA005491B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Настоящее изобретение относится к способу получения циталопрама, который включает взаимодействие соединения формулы (II) с соединением, имеющим формулу (III), где R представляет собой галоген или -O-SO-X, где Х представляет собой алкил, алкенил, алкинил или необязательно алкилзамещенный арил или аралкил и Rпредставляет собой диметиламино, галоген или -O-SO-X, где Х такой, как определен выше, при условии, что R не является галогеном, когда Rпредставляет собой диметиламино; и если Rпредставляет собой диметиламино, с последующим выделением основания циталопрама или его фармацевтически приемлемой соли добавления кислот, и если Rпредставляет собой галоген или -O-SO-X, где Х такой, как определен выше, с последующим преобразованием полученного соединения формулы, где Rпредставляет собой галоген или группу формулы -O-SO-X, где Х такой как определен выше, в циталопрам, с последующим выделением основания циталопрама или его фармацевтически приемлемой соли добавления кислот.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200939A 2000-03-03 2001-03-01 Способ получения циталопрама EA005491B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000353 2000-03-03
PCT/DK2001/000140 WO2001051478A1 (en) 2000-03-03 2001-03-01 Method for the preparation of citalopram

Publications (2)

Publication Number Publication Date
EA200200939A1 true EA200200939A1 (ru) 2003-02-27
EA005491B1 EA005491B1 (ru) 2005-02-24

Family

ID=8159277

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200939A EA005491B1 (ru) 2000-03-03 2001-03-01 Способ получения циталопрама

Country Status (29)

Country Link
US (1) US6768011B2 (ru)
EP (1) EP1263750A1 (ru)
JP (1) JP2003519692A (ru)
KR (1) KR20020080450A (ru)
CN (1) CN1411454A (ru)
AR (1) AR027559A1 (ru)
AU (1) AU2001240469A1 (ru)
BE (1) BE1011481A6 (ru)
BG (1) BG107050A (ru)
BR (1) BR0109022A (ru)
CA (1) CA2401374A1 (ru)
EA (1) EA005491B1 (ru)
FR (1) FR2805814A1 (ru)
GR (1) GR1003795B (ru)
HR (1) HRP20020742A2 (ru)
HU (1) HUP0300060A3 (ru)
IE (1) IES20010157A2 (ru)
IL (1) IL151467A0 (ru)
IS (1) IS6526A (ru)
IT (1) ITMI20010444A1 (ru)
MX (1) MXPA02008634A (ru)
NL (1) NL1017417C1 (ru)
NO (1) NO20024180D0 (ru)
NZ (1) NZ521200A (ru)
PL (1) PL358543A1 (ru)
SK (1) SK14152002A3 (ru)
TR (1) TR200202096T2 (ru)
WO (1) WO2001051478A1 (ru)
ZA (1) ZA200206846B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
CN1429219A (zh) 2000-03-13 2003-07-09 H·隆德贝克有限公司 制备西酞普兰的方法
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
ATE257832T1 (de) 2000-03-14 2004-01-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
EP1446396A1 (en) * 2001-11-08 2004-08-18 Sepracor, Inc. Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
TWI306846B (en) 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (ru) 1965-03-18
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
DK1015416T3 (da) 1997-07-08 2001-11-05 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
EA002770B1 (ru) 1997-11-11 2002-08-29 Х.Лундбекк А/С Способ получения циталопрама
KR100411505B1 (ko) 1998-10-20 2003-12-18 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
CA2356188C (en) 1998-12-23 2006-05-23 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
ES2229774T3 (es) 1999-10-25 2005-04-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
SI1246812T1 (en) 1999-12-28 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
HUP0203840A3 (en) 1999-12-30 2005-02-28 Lundbeck & Co As H Method for the preparation of citalopram
IL150561A0 (en) 2000-01-14 2003-02-12 Lundbeck & Co As H Method for the preparation of 5-cyanophthalide
IT1317729B1 (it) 2000-01-18 2003-07-15 Norpharma S P A Procedimento per la preparazione della 5-carbossiftalide.
US6433196B1 (en) 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
IES20010143A2 (en) 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
NL1017415C1 (nl) * 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
CN1429219A (zh) 2000-03-13 2003-07-09 H·隆德贝克有限公司 制备西酞普兰的方法
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
ATE257832T1 (de) 2000-03-14 2004-01-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
TR200202168T2 (tr) 2000-03-16 2002-12-23 H. Lundbeck A/S 5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
AU2001272368A1 (en) 2000-07-06 2002-01-21 H. Lundbeck, A/S Method for the preparation of citalopram
FI20011621A (fi) 2000-08-18 2002-02-19 Lundbeck & Co As H Menetelmä sitalopraamin valmistamiseksi
EA003581B1 (ru) 2000-12-22 2003-06-26 Х.Лундбекк А/С Способ получения чистого циталопрама
EA003459B1 (ru) 2000-12-28 2003-06-26 Х.Лундбекк А/С Способ получения чистого циталопрама

Also Published As

Publication number Publication date
IL151467A0 (en) 2003-04-10
NZ521200A (en) 2004-03-26
ITMI20010444A1 (it) 2002-09-05
EA005491B1 (ru) 2005-02-24
WO2001051478A1 (en) 2001-07-19
BG107050A (en) 2003-05-30
BR0109022A (pt) 2003-06-03
PL358543A1 (en) 2004-08-09
BE1011481A6 (fr) 2001-07-03
GR1003795B (el) 2002-02-08
CN1411454A (zh) 2003-04-16
EP1263750A1 (en) 2002-12-11
IS6526A (is) 2002-08-27
HUP0300060A3 (en) 2005-02-28
NL1017417C1 (nl) 2001-03-16
HUP0300060A2 (en) 2003-05-28
JP2003519692A (ja) 2003-06-24
US6768011B2 (en) 2004-07-27
FR2805814A1 (fr) 2001-09-07
KR20020080450A (ko) 2002-10-23
US20030092761A1 (en) 2003-05-15
NO20024180L (no) 2002-09-02
SK14152002A3 (sk) 2003-03-04
NO20024180D0 (no) 2002-09-02
CA2401374A1 (en) 2001-07-19
ZA200206846B (en) 2003-08-27
MXPA02008634A (es) 2003-02-24
AU2001240469A1 (en) 2001-07-24
TR200202096T2 (tr) 2003-01-21
IES20010157A2 (en) 2002-03-06
AR027559A1 (es) 2003-04-02
HRP20020742A2 (en) 2004-02-29

Similar Documents

Publication Publication Date Title
GR20010100097A (el) Μεθοδος παρασκευης της σιταλοπραμης
SI1781683T1 (sl) Postopek za pripravo 17-vinil-triflatov kot intermediatov
EA200200898A1 (ru) Способ получения циталопрама
EA200101081A1 (ru) Способ получения циталопрама
EA200200939A1 (ru) Способ получения циталопрама
IS6859A (is) Kristölluð form atorvastatíns
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
EA200201071A1 (ru) Циклопентилзамещенные производные глутарамида в качестве ингибиторов нейтральной эндопептидазы
EA200400129A1 (ru) Способ получения периндоприла, его аналогов и солей с использованием 2,5-диоксооксазолидиновых промежуточных соединений
BR0109048A (pt) Processo para a sìntese de citalopram
EA200200719A1 (ru) Способ получения циталопрама
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
EA199800792A1 (ru) Способы получения промежуточных соединений для пестицидов
HUP0300856A2 (hu) Eljárás szubsztituált fenil-acetonitrilek elżállítására
NO20002589D0 (no) Bifenylamidinderivater
EA200200970A1 (ru) Способ получения циталопрама
EA200100213A1 (ru) Способ синтеза производных (1h)-бензо[c]хинолизин-3-онов
EA200100593A1 (ru) Способ получения циталопрама
EA200000924A2 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
EA200200971A1 (ru) Способ получения циталопрама
NO20033049L (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin
MXPA03011647A (es) Procedimiento de resolucion para el acido ( r ) - (-) - 2-hidroxi - 2- (2 - clorofenil) acetico.
EA200500032A1 (ru) Производные ацилоксипирролидина и их применение в качестве лигандов v1b или v1b и v1a рецепторов
TW200503701A (en) Novel intermediate for the preparation of therapeutically active imidazopyridines
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU